Anda belum login :: 11 Jul 2025 10:00 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Goldfrank's toxicologic emergencies
Bibliografi
Author:
Nelson, Lewis S.
(Editor);
Howland, Mary Ann
(Editor);
Lewin, Neal A.
(Editor);
Smith, Silas W.
(Editor);
Goldfrank, Lewis R.
(Editor);
Hoffman, Robert S.
(Editor)
Topik:
Emergencies
;
Poisoning
;
Poisons
Bahasa:
(EN )
ISBN:
978-1-259-85961-8
Edisi:
11th.
Penerbit:
McGraw-Hill Education
Tempat Terbit:
New York
Tahun Terbit:
2019
Jenis:
Books - E-Book
Fulltext:
cover_9781259859618_fc.pdf
(561.73KB;
0 download
)
Copyright.pdf
(68.22KB;
0 download
)
Notice.pdf
(58.21KB;
0 download
)
Editors.pdf
(72.79KB;
0 download
)
Neal E. Flomenbaum, MD, FACP, FACEP.pdf
(85.78KB;
0 download
)
Epigraph.pdf
(62.82KB;
0 download
)
Dedication.pdf
(60.93KB;
0 download
)
Antidotes in Depth.pdf
(64.89KB;
0 download
)
Contributors.pdf
(212.09KB;
0 download
)
Preface.pdf
(68.81KB;
0 download
)
Acknowledgments.pdf
(61.8KB;
0 download
)
Chapter 1_ Historical Principles and Perspectives.pdf
(389.97KB;
0 download
)
Chapter 2_ Toxicologic Misfortunes and Catastrophes in History.pdf
(317.42KB;
0 download
)
Case Study 1.pdf
(87.57KB;
0 download
)
Chapter 3_ Initial Evaluation of The Patient_ Vital Signs and Toxic Syndromes.pdf
(158.65KB;
0 download
)
Case Study 2.pdf
(91.58KB;
0 download
)
Chapter 4_ Principles of Managing the Acutely Poisoned or Overdosed Patient.pdf
(329.25KB;
0 download
)
Chapter SC1_ Principles of Antidote Stocking.pdf
(221.85KB;
0 download
)
Chapter 5_ Techniques Used to Prevent Gastrointestinal Absorption.pdf
(1.27MB;
0 download
)
Chapter SC2_ Decontamination Principles_ Prevention of Dermal, Ophthalmic, and Inhalational Absorption.pdf
(170.26KB;
0 download
)
Chapter A1_ Activated Charcoal.pdf
(311.25KB;
0 download
)
Chapter A2_ Whole-Bowel Irrigation and Other Intestinal Evacuants.pdf
(282.29KB;
0 download
)
Chapter 6_ Principles and Techniques Applied to Enhance Elimination.pdf
(559.97KB;
0 download
)
Chapter 7_ Laboratory Principles.pdf
(529.69KB;
0 download
)
Chapter 8_ Principles of Diagnostic Imaging.pdf
(2.46MB;
0 download
)
Chapter 9_ Pharmacokinetic and Toxicokinetic Principles.pdf
(1,019.9KB;
0 download
)
Chapter 10_ Chemical Principles.pdf
(707.45KB;
0 download
)
Chapter 11_ Biochemical and Metabolic Principles.pdf
(984.44KB;
0 download
)
Chapter 12_ Fluid, Electrolyte, and Acid–Base Principles.pdf
(456.36KB;
0 download
)
Chapter 13_ Neurotransmitters and Neuromodulators.pdf
(1.46MB;
0 download
)
Chapter 14_ Withdrawal Principles.pdf
(266.91KB;
0 download
)
Case Study 3.pdf
(175.04KB;
0 download
)
Chapter 15_ Cardiologic Principles I_ Electrophysiologic and Electrocardiographic Principles.pdf
(1.65MB;
0 download
)
Chapter 16_ Cardiologic Principles II_ Hemodynamics.pdf
(422.65KB;
0 download
)
Case Study 4.pdf
(141.75KB;
0 download
)
Chapter 17_ Dermatologic Principles.pdf
(1.43MB;
0 download
)
Chapter SC3_ Transdermal Toxicology.pdf
(163.85KB;
0 download
)
Chapter 18_ Gastrointestinal Principles.pdf
(687.31KB;
0 download
)
Chapter 19_ Genitourinary Principles.pdf
(772.91KB;
0 download
)
Chapter 20_ Hematologic Principles.pdf
(634.84KB;
0 download
)
Chapter 21_ Hepatic Principles.pdf
(720.97KB;
0 download
)
Case Study 5.pdf
(88.22KB;
0 download
)
Chapter 22_ Neurologic Principles.pdf
(294.57KB;
0 download
)
Chapter 23_ Oncologic Principles.pdf
(441.41KB;
0 download
)
Chapter 24_ Ophthalmic Principles.pdf
(334.68KB;
0 download
)
Chapter 25_ Otolaryngologic Principles.pdf
(527.27KB;
1 download
)
Chapter 26_ Psychiatric Principles.pdf
(260.44KB;
0 download
)
Chapter SC4_ Patient Violence.pdf
(175.37KB;
0 download
)
Chapter 27_ Renal Principles.pdf
(815.79KB;
0 download
)
Chapter 28_ Respiratory Principles.pdf
(759.0KB;
0 download
)
Chapter 29_ Thermoregulatory Principles.pdf
(744.67KB;
0 download
)
Chapter 30_ Reproductive and Perinatal Principles.pdf
(637.11KB;
0 download
)
Chapter 31_ Pediatric Principles.pdf
(391.85KB;
0 download
)
Case Study 6.pdf
(80.27KB;
0 download
)
Chapter 32_ Geriatric Principles.pdf
(388.24KB;
0 download
)
Chapter 33_ Acetaminophen.pdf
(836.43KB;
0 download
)
Chapter A3_ N-Acetylcysteine.pdf
(401.11KB;
0 download
)
Chapter 34_ Colchicine, Podophyllin, and the Vinca Alkaloids.pdf
(486.99KB;
0 download
)
Chapter 35_ Nonsteroidal Antiinflammatory Drugs.pdf
(351.58KB;
0 download
)
Chapter 36_ Opioids.pdf
(714.27KB;
0 download
)
Chapter A4_ Opioid Antagonists.pdf
(291.04KB;
0 download
)
Chapter SC5_ Internal Concealment of Xenobiotics.pdf
(427.44KB;
0 download
)
Chapter SC6_ Prevention, Treatment, and Harm Reduction Approaches to Opioid Overdoses.pdf
(153.76KB;
0 download
)
Chapter 37_ Salicylates.pdf
(501.86KB;
0 download
)
Chapter A5_ Sodium Bicarbonate.pdf
(275.52KB;
0 download
)
Chapter 38_ Botulism.pdf
(437.92KB;
0 download
)
Chapter A6_ Botulinum Antitoxin.pdf
(225.69KB;
0 download
)
Chapter 39_ Food Poisoning.pdf
(556.12KB;
0 download
)
Chapter 40_ Dieting Xenobiotics and Regimens.pdf
(543.94KB;
0 download
)
Chapter 41_ Athletic Performance Enhancers.pdf
(441.29KB;
0 download
)
Chapter 42_ Essential Oils.pdf
(472.48KB;
0 download
)
Chapter 43_ Plant- and Animal-Derived Dietary Supplements.pdf
(454.97KB;
0 download
)
Chapter 44_ Vitamins.pdf
(600.66KB;
0 download
)
Chapter 45_ Iron.pdf
(527.37KB;
0 download
)
Chapter A7_ Deferoxamine.pdf
(266.93KB;
1 download
)
Chapter 46_ Pharmaceutical Additives.pdf
(492.05KB;
0 download
)
Chapter 47_ Antidiabetics and Hypoglycemics_Antiglycemics.pdf
(640.03KB;
0 download
)
Chapter A8_ Dextrose (D-Glucose).pdf
(284.79KB;
0 download
)
Chapter A9_ Octreotide.pdf
(279.18KB;
0 download
)
Chapter 48_ Antiepileptics.pdf
(618.81KB;
0 download
)
Chapter A10_ L-Carnitine.pdf
(175.51KB;
0 download
)
Case Study 7.pdf
(189.91KB;
0 download
)
Chapter 49_ Antihistamines and Decongestants.pdf
(893.08KB;
0 download
)
Chapter A11_ Physostigmine Salicylate.pdf
(259.93KB;
0 download
)
Chapter 50_ Chemotherapeutics.pdf
(565.41KB;
0 download
)
Chapter 51_ Methotrexate, 5-Fluorouracil, and Capecitabine.pdf
(394.44KB;
0 download
)
Chapter A12_ Folates_ Leucovorin (Folinic Acid) and Folic Acid.pdf
(368.77KB;
0 download
)
Chapter A13_ Glucarpidase (Carboxypeptidase G2).pdf
(466.91KB;
0 download
)
Chapter A14_ Uridine Triacetate.pdf
(186.75KB;
0 download
)
Chapter SC7_ Intrathecal Administration of Xenobiotics.pdf
(290.92KB;
0 download
)
Chapter SC8_ Extravasation of Xenobiotics.pdf
(161.73KB;
0 download
)
Chapter 52_ Antimigraine Medications.pdf
(353.58KB;
0 download
)
Chapter 53_ Thyroid and Antithyroid Medications.pdf
(374.37KB;
0 download
)
Chapter 54_ Antibacterials, Antifungals, and Antivirals.pdf
(778.67KB;
0 download
)
Chapter 55_ Antimalarials.pdf
(583.34KB;
0 download
)
Chapter 56_ Antituberculous Medications.pdf
(529.29KB;
0 download
)
Chapter A15_ Pyridoxine.pdf
(165.64KB;
0 download
)
Chapter 57_ Antidysrhythmics.pdf
(460.76KB;
0 download
)
Chapter A16_ Magnesium.pdf
(273.29KB;
0 download
)
Chapter 58_ Antithrombotics.pdf
(1.2MB;
0 download
)
Chapter A17_ Prothrombin Complex Concentrates and Direct Oral Anticoagulant Antidotes.pdf
(283.96KB;
0 download
)
Chapter A18_ Vitamin K1.pdf
(187.5KB;
0 download
)
Chapter A19_ Protamine.pdf
(256.2KB;
0 download
)
Case Study 8.pdf
(150.66KB;
0 download
)
Chapter 59_ ß-Adrenergic Antagonists.pdf
(760.39KB;
0 download
)
Chapter A20_ Glucagon.pdf
(217.16KB;
0 download
)
Chapter 60_ Calcium Channel Blockers.pdf
(439.01KB;
0 download
)
Chapter A21_ High-Dose Insulin.pdf
(584.08KB;
0 download
)
Chapter 61_ Miscellaneous Antihypertensives and Pharmacologically Related Agents.pdf
(484.94KB;
0 download
)
Chapter 62_ Cardioactive Steroids.pdf
(588.15KB;
0 download
)
Chapter A22_ Digoxin-Specific Antibody Fragments.pdf
(292.73KB;
0 download
)
Chapter 63_ Methylxanthines and Selective ß2-Adrenergic Agonists.pdf
(325.2KB;
0 download
)
Chapter 64_ Local Anesthetics.pdf
(507.28KB;
0 download
)
Chapter A23_ Lipid Emulsion.pdf
(225.33KB;
0 download
)
Chapter 65_ Inhalational Anesthetics.pdf
(408.39KB;
0 download
)
Chapter 66_ Neuromuscular Blockers.pdf
(469.04KB;
0 download
)
Chapter A24_ Dantrolene Sodium.pdf
(146.18KB;
0 download
)
Chapter 67_ Antipsychotics.pdf
(423.81KB;
0 download
)
Chapter 68_ Cyclic Antidepressants.pdf
(832.4KB;
0 download
)
Chapter 69_ Serotonin Reuptake Inhibitors and Atypical Antidepressants.pdf
(459.86KB;
0 download
)
Chapter 70_ Lithium.pdf
(507.51KB;
0 download
)
Chapter 71_ Monoamine Oxidase Inhibitors.pdf
(483.82KB;
0 download
)
Chapter 72_ Sedative–Hypnotics.pdf
(454.43KB;
0 download
)
Chapter A25_ Flumazenil.pdf
(246.53KB;
0 download
)
Chapter 73_ Amphetamines.pdf
(550.67KB;
0 download
)
Chapter 74_ Cannabinoids.pdf
(860.92KB;
0 download
)
Chapter 75_ Cocaine.pdf
(491.73KB;
0 download
)
Chapter A26_ Benzodiazepines.pdf
(486.4KB;
0 download
)
Chapter 76_ Ethanol.pdf
(597.96KB;
0 download
)
Chapter A27_ Thiamine Hydrochloride.pdf
(436.42KB;
0 download
)
Chapter 77_ Alcohol Withdrawal.pdf
(241.09KB;
0 download
)
Chapter 78_ Disulfiram and Disulfiramlike Reactions.pdf
(331.76KB;
0 download
)
Chapter 79_ Hallucinogens.pdf
(477.59KB;
0 download
)
Chapter 80_ ?-Hydroxybutyric Acid (?-Hydroxybutyrate).pdf
(301.59KB;
0 download
)
Chapter 81_ Inhalants.pdf
(559.75KB;
0 download
)
Chapter 82_ Nicotine.pdf
(324.11KB;
0 download
)
Chapter 83_ Phencyclidine and Ketamine.pdf
(526.8KB;
0 download
)
Case Study 9.pdf
(94.33KB;
0 download
)
Chapter 84_ Aluminum.pdf
(232.61KB;
0 download
)
Chapter 85_ Antimony.pdf
(367.14KB;
0 download
)
Chapter 86_ Arsenic.pdf
(769.99KB;
0 download
)
Chapter A28_ Dimercaprol (British Anti-Lewisite or BAL).pdf
(182.76KB;
0 download
)
Chapter 87_ Bismuth.pdf
(196.35KB;
0 download
)
Chapter 88_ Cadmium.pdf
(248.86KB;
0 download
)
Chapter 89_ Cesium.pdf
(212.01KB;
0 download
)
Chapter 90_ Chromium.pdf
(207.27KB;
0 download
)
Chapter 91_ Cobalt.pdf
(386.67KB;
0 download
)
Chapter 92_ Copper.pdf
(449.3KB;
0 download
)
Chapter 93_ Lead.pdf
(814.55KB;
0 download
)
Chapter A29_ Succimer (2,3-Dimercaptosuccinic Acid) and Dmps (2,3-Dimercapto-1-Propanesulfonic Acid).pdf
(371.55KB;
0 download
)
Chapter A30_ Edetate Calcium Disodium (CaNa2Edta).pdf
(209.97KB;
0 download
)
Chapter 94_ Manganese.pdf
(279.64KB;
0 download
)
Chapter 95_ Mercury.pdf
(340.14KB;
0 download
)
Chapter 96_ Nickel.pdf
(272.27KB;
0 download
)
Chapter 97_ Selenium.pdf
(281.52KB;
0 download
)
Chapter 98_ Silver.pdf
(406.77KB;
0 download
)
Chapter 99_ Thallium.pdf
(357.55KB;
0 download
)
Chapter A31_ Prussian Blue.pdf
(210.58KB;
0 download
)
Chapter 100_ Zinc.pdf
(246.6KB;
0 download
)
Chapter 101_ Antiseptics, Disinfectants, and Sterilants.pdf
(430.98KB;
0 download
)
Chapter 102_ Camphor and Moth Repellents.pdf
(449.3KB;
0 download
)
Chapter 103_ Caustics.pdf
(524.78KB;
0 download
)
Chapter 104_ Hydrofluoric Acid and Fluorides.pdf
(283.64KB;
0 download
)
Chapter A32_ Calcium.pdf
(306.51KB;
0 download
)
Chapter 105_ Hydrocarbons.pdf
(545.77KB;
0 download
)
Case Study 10.pdf
(92.16KB;
0 download
)
Chapter 106_ Toxic Alcohols.pdf
(638.51KB;
0 download
)
Chapter A33_ Fomepizole.pdf
(220.01KB;
0 download
)
Chapter A34_ Ethanol.pdf
(230.9KB;
0 download
)
Chapter SC9_ Diethylene Glycol.pdf
(254.33KB;
0 download
)
Case Study 11.pdf
(198.81KB;
0 download
)
Chapter 107_ Barium.pdf
(160.39KB;
0 download
)
Chapter 108_ Fumigants.pdf
(380.2KB;
0 download
)
Chapter 109_ Herbicides.pdf
(714.46KB;
0 download
)
Chapter 110_ Insecticides_ Organic Phosphorus Compounds and Carbamates.pdf
(835.34KB;
0 download
)
Chapter A35_ Atropine.pdf
(261.88KB;
0 download
)
Chapter A36_ Pralidoxime.pdf
(291.21KB;
0 download
)
Chapter 111_ Insecticides_ Organic Chlorines, Pyrethrins_Pyrethroids, and Insect Repellents.pdf
(720.41KB;
0 download
)
Chapter 112_ Phosphorus.pdf
(165.38KB;
0 download
)
Chapter 113_ Sodium Monofluoroacetate and Fluoroacetamide.pdf
(154.61KB;
0 download
)
Chapter 114_ Strychnine.pdf
(209.59KB;
0 download
)
Chapter 115_ Arthropods.pdf
(974.85KB;
0 download
)
Chapter A37_ Antivenom_ Spider.pdf
(195.99KB;
0 download
)
Chapter A38_ Antivenom_ Scorpion.pdf
(174.69KB;
0 download
)
Chapter 116_ Marine Envenomations.pdf
(910.14KB;
0 download
)
Chapter 117_ Mushrooms.pdf
(1.24MB;
0 download
)
Chapter 118_ Plants.pdf
(1.17MB;
0 download
)
Chapter 119_ Native (US) Venomous Snakes and Lizards.pdf
(778.49KB;
0 download
)
Chapter A39_ Antivenom for North American Venomous Snakes (Crotaline and Elapid).pdf
(326.45KB;
0 download
)
Chapter SC10_ Exotic Nonnative Snake Envenomations.pdf
(205.33KB;
0 download
)
Case Study 12.pdf
(104.95KB;
0 download
)
Chapter 120_ Smoke Inhalation.pdf
(773.86KB;
0 download
)
Case Study 13.pdf
(76.54KB;
0 download
)
Chapter 121_ Simple Asphyxiants and Pulmonary Irritants.pdf
(451.84KB;
0 download
)
Chapter 122_ Carbon Monoxide.pdf
(565.12KB;
0 download
)
Chapter A40_ Hyperbaric Oxygen.pdf
(462.85KB;
0 download
)
Chapter 123_ Cyanide and Hydrogen Sulfide.pdf
(431.2KB;
0 download
)
Chapter A41_ Hydroxocobalamin.pdf
(217.51KB;
0 download
)
Chapter A42_ Nitrites (Amyl and Sodium) and Sodium Thiosulfate.pdf
(218.59KB;
0 download
)
Chapter 124_ Methemoglobin Inducers.pdf
(688.98KB;
0 download
)
Chapter A43_ Methylene Blue.pdf
(165.71KB;
0 download
)
Chapter 125_ Nanotoxicology.pdf
(884.3KB;
0 download
)
Chapter 126_ Chemical Weapons.pdf
(555.98KB;
0 download
)
Chapter 127_ Biological Weapons.pdf
(727.41KB;
0 download
)
Chapter 128_ Radiation.pdf
(345.19KB;
0 download
)
Chapter A44_ Potassium Iodide.pdf
(166.79KB;
0 download
)
Chapter A45_ Pentetic Acid or Pentetate (Zinc or Calcium) Trisodium (DTPA).pdf
(155.59KB;
0 download
)
Chapter 129_ Poison Prevention and Education.pdf
(269.49KB;
0 download
)
Chapter 130_ Poison Control Centers and Poison Epidemiology.pdf
(262.94KB;
0 download
)
Chapter 131_ Principles of Occupational Toxicology_ Diagnosis and Control.pdf
(194.93KB;
0 download
)
Chapter 132_ Hazardous Materials Incident Response.pdf
(389.25KB;
0 download
)
Chapter 133_ Risk Assessment and Risk Communication.pdf
(188.47KB;
0 download
)
Case Study 14.pdf
(234.64KB;
0 download
)
Chapter 134_ Medication Safety and Adverse Drug Events.pdf
(410.21KB;
0 download
)
Chapter 135_ Drug Development, Adverse Drug Events, and Postmarketing Surveillance.pdf
(310.53KB;
0 download
)
Chapter 136_ International Perspectives on Medical Toxicology.pdf
(292.32KB;
0 download
)
Chapter 137_ Principles of Epidemiology and Research Design.pdf
(421.43KB;
0 download
)
Chapter 138_ Risk Management and Legal Principles.pdf
(184.0KB;
0 download
)
Chapter 139_ Medicolegal Interpretive Toxicology.pdf
(262.31KB;
0 download
)
Chapter SC11_ Assessment of Ethanol-Induced Impairment.pdf
(248.28KB;
0 download
)
Chapter 140_ Postmortem Toxicology.pdf
(275.93KB;
0 download
)
Chapter SC12_ Organ Procurement From Poisoned Patients.pdf
(156.9KB;
0 download
)
Interview with Dr. Lewis Goldfrank.pdf
(188.48KB;
0 download
)
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Lihat Sejarah Pengadaan
Konversi Metadata
Kembali
Process time: 0.125 second(s)
